Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-107,890
Closed -$3.37M 273
2024
Q3
$3.37M Buy
+107,890
New +$2.68M 0.5% 103
2021
Q1
Sell
-30,186
Closed -$2.19M 351
2020
Q4
$2.19M Buy
+30,186
New +$1.75M 0.36% 93
2019
Q3
Sell
-52,504
Closed -$1.89M 242
2019
Q2
$1.89M Sell
52,504
-171
-0.3% -$5.47K 0.46% 74
2019
Q1
$1.66M Sell
52,675
-90,752
-63% -$2.64M 0.41% 95
2018
Q4
$3.61M Buy
143,427
+59,317
+71% +$1.52M 0.98% 4
2018
Q3
$2.43M Sell
84,110
-59,391
-41% -$1.11M 0.36% 134
2018
Q2
$1.76M Sell
143,501
-78,918
-35% -$905K 0.28% 162
2018
Q1
$1.77M Sell
222,419
-2,204
-1% -$13.6K 0.3% 151
2017
Q4
$1.65M Buy
+224,623
New +$1.4M 0.3% 161

Other funds holding CDNA

EAM Investors's CDNA Position: Q4 2024 in Review

EAM Investors sold out of CareDx (CDNA) in Q4 2024, closing a stake of 107,890 shares — an estimated $3.37M sold.

EAM Investors first reported a position in CDNA in Q4 2017 and held it in 9 quarters. The position peaked at $3.61M in Q4 2018. 210 funds tracked by Wall St. Rank hold CDNA as of Q4 2024.

  • EAM Investors reported no remaining CareDx position as of Q4 2024 after selling out during the quarter.
  • EAM Investors sold 107,890 CareDx shares in Q4 2024, an estimated $3.37M.
  • EAM Investors first reported a position in CareDx in Q4 2017 and held it in 9 quarters.
  • EAM Investors's CareDx position peaked at $3.61M in Q4 2018.
  • 210 funds tracked by Wall St. Rank held CareDx as of Q4 2024.

Based on EAM Investors's 13F filing for Q4 2024, filed 13 Feb 2025.